硅寶科技(300019.SZ):擬向安徽硅寶增資4166萬元
格隆匯9月29日丨硅寶科技(300019.SZ)公佈,公司2022年9月29日召開第六屆董事會等四次會議,審議通過《關於使用自有資金或自籌資金增資全資子公司的議案》,公司同意使用自有資金或自籌資金向全資子公司安徽硅寶有機硅新材料有限公司(簡稱“安徽硅寶”)增資4166萬元,同時安徽硅寶以資本公積轉增註冊資本1764萬元,主要用於安徽硅寶產能擴充及業務發展。增資完成後,安徽硅寶仍是公司全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.